Is Cannabidiol the Cure-all Remedy we Have Been Looking for?| Biomed GridJournal
: American Journal of Biomedical Science & Research (Vol.3, No. 2)
Publication Date: 2019-05-24
Authors : Leona Chang; Olga Ostrovsky;
Page : 118-120
Keywords : Biomedical Science and Research Journals; biomedical open access journals; biomedical research journals; Biomed Grid; open access journals of biomedical science;
Source : Download Find it from : Google Scholar
Cannabidiol (CBD), the second major component of the plant Cannabis sativa, has become increasingly popular for its potential anxiolytic, antiinflammatory, antiemetic, and antipsychotic effects. It is non-psychotropic and has no abusive potential thus far, however scientific evidence on the pharmacological effects of CBD are limited to preclinical studies. More large and well-controlled clinical trials are needed to establish the clinical applications of CBD.
Cannabis sativa is one of three primary species from the Cannabaceae family, known for its cannabinoid extract, delta-9-tetrahydrocannabinol (Δ9-THC,). Δ9-THC is the most abundant component of Cannabis sativa and is popular for its psychoactive or euphoric effects. On the contrary, the second major component of the plant Cannabis sativa-cannabidiol (CBD)-does not have psychoactive effects; it has received the latest media buzz and marketing claims as a miracle cure for anxiety, depression, pain, inflammation, insomnia, and even cancer, without the high.
Last modified: 2019-06-12 15:11:51